O-Demethyl Lenvatinib hydrochloride, a metabolite of Lenvatinib (E7080), is an orally administered multi-targeted tyrosine kinase inhibitor. It targets and inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, demonstrating potent antitumor activities [1] [2]
Molecular Weight:
449.29
Formula:
C20H18Cl2N4O4
* VAT and and shipping costs not included. Errors and price changes excepted
